Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Banken

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 15, 2025
Palliative management of patients with locally recurrent rectal cancer: Clinical presentation, treatment strategies, and overall survivalE Banken, D M J Creemers, F E C Vande Kerckhove, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 23, 2025
Neoadjuvant chemotherapy and chemoradiotherapy versus chemoradiotherapy alone in high-risk locally advanced rectal cancer: A retrospective comparison of two Dutch tertiary referral centresK van den Berg, E Banken, J M van Rees, et al.
Journal of Geriatric Oncology|May 3, 2026
A multidisciplinary care pathway for colorectal carcinoma: Impact on treatment decisionsJ Lagarde, E Banken, I E G van Hellemond, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2026
Toxicity and Treatment Completion of Neoadjuvant FOLFOXIRI and Chemoradiotherapy in patients with High-Risk Locally Advanced Rectal Cancer: A Secondary Outcome Analysis of the MEND-IT TrialE Banken, K van den Berg, I E G van Hellemond, et al.
Radiation Oncology (London, England)|December 23, 2025
Neoadjuvant chemo-reirradiation followed by resection and intraoperative electron beam radiotherapy: outcomes of multimodality treatment for locally recurrent rectal cancerF E C Vande Kerckhove, F Piqeur, E Banken, et al.
Annals of Surgical Oncology|January 22, 2026
Locally Recurrent Rectal Cancer in the Lateral Compartment: Imaging Features and Association with Primary Tumour CharacteristicsF E C Vande Kerckhove, D M J Creemers, E Banken, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 24, 2025
Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohortD M J Creemers, D M Mens, S Nordkamp, et al.
BMC Cancer|May 19, 2026
A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trialE Banken, M Borg, I E G van Hellemond, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 15, 2025
Palliative management of patients with locally recurrent rectal cancer: Clinical presentation, treatment strategies, and overall survivalE Banken, D M J Creemers, F E C Vande Kerckhove, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 23, 2025
Neoadjuvant chemotherapy and chemoradiotherapy versus chemoradiotherapy alone in high-risk locally advanced rectal cancer: A retrospective comparison of two Dutch tertiary referral centresK van den Berg, E Banken, J M van Rees, et al.
Journal of Geriatric Oncology|May 3, 2026
A multidisciplinary care pathway for colorectal carcinoma: Impact on treatment decisionsJ Lagarde, E Banken, I E G van Hellemond, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2026
Toxicity and Treatment Completion of Neoadjuvant FOLFOXIRI and Chemoradiotherapy in patients with High-Risk Locally Advanced Rectal Cancer: A Secondary Outcome Analysis of the MEND-IT TrialE Banken, K van den Berg, I E G van Hellemond, et al.
Radiation Oncology (London, England)|December 23, 2025
Neoadjuvant chemo-reirradiation followed by resection and intraoperative electron beam radiotherapy: outcomes of multimodality treatment for locally recurrent rectal cancerF E C Vande Kerckhove, F Piqeur, E Banken, et al.
Annals of Surgical Oncology|January 22, 2026
Locally Recurrent Rectal Cancer in the Lateral Compartment: Imaging Features and Association with Primary Tumour CharacteristicsF E C Vande Kerckhove, D M J Creemers, E Banken, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 24, 2025
Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohortD M J Creemers, D M Mens, S Nordkamp, et al.
BMC Cancer|May 19, 2026
A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trialE Banken, M Borg, I E G van Hellemond, et al.
Pageof 1